INTRODUCTION:

Electric tattoos, often referred to as epidermal electronic systems or electronic tattoos, are incredibly thin, flexible, and skin-conforming devices that are made to resemble human skin in some ways. Heart rate, body temperature, muscular activity, hydration levels, and other physiological parameters may be continuously and non-invasively monitored thanks to these cutting-edge devices that incorporate electronics onto stretchy substrates that can stick to the skin's surface. Electric tattoos are perfect for long-term biomedical applications because they are lightweight, undetectable to the user, and can continue to work even when the wearer is moving or perspiring, unlike typical wearable technology.^1,2,3

Electric tattoos have become a viable platform for innovative medicine delivery methods in recent years. These devices allow for accurate and programmable transdermal administration of drugs by integrating features like controlled heating elements, iontophoresis (electrically-assisted drug transport), or micro-needles. Compared to traditional techniques, this strategy has a number of benefits, such as increased patient compliance, less discomfort, and tailored release of drugs. By reacting to real-time physiological data, electric tattoos may be made to administer drugs only when necessary and in the right dosages, improving therapeutic effectiveness and lowering adverse effects.^4,5

Furthermore, the ability to wirelessly control or monitor the drug release process allows for integration with digital health systems, offering a smart and personalized medicine platform. This innovation holds great potential for managing chronic diseases, pain relief, hormone therapy, and even vaccination strategies. As research advances, electric tattoos are likely to revolutionize the field of transdermal drug delivery, offering a futuristic alternative to pills and injections.

1. Advantages:

· On-Demand Delivery:

Electrically gated nanoporous membranes or iontophoretic actuators, which regulate the release of drugs by applying voltage, can be used into electric tattoos⁶.

· Enhanced Drug Penetration:

Methods such as iontophoresis (continuous low-current) and electroporation (brief high-voltage pulses) enable drugs, even big hydrophilic macromolecules like insulin, peptides, and DNA, to pass through the stratum corneum barrier, which would otherwise prevent transdermal administration^7,8.

· Minimally Invasive Wearables:

Even when stretched or perspiring, these very thin, breathable, and skin-conforming devices are frequently undetectable and low-profile. Long-term wearability and user comfort are enhanced by this⁹.

· Integration with Monitoring and Wireless Control:

In addition to administering drugs, electric tattoos may also track physiological data (such as temperature and ECG/EMG signals) and can be wirelessly connected to allow for feedback-controlled, intelligent, closed-loop treatment ¹⁰.

2. Disadvantages and Challenges:

· Biocompatibility and Skin Safety:

Long-term contact may provoke skin irritation, allergic responses, local infection, or other dermal reactions. Rigorous biocompatibility and chronic safety evaluations are still needed⁶.

· Technical Limitations and Device Reliability:

Engineering issues still include things like mechanical durability under stress, steady electrical performance, thermal management, and device interconnection—all of which must be addressed over the course of hours or days of movement or perspiration¹¹.

· Drug Loading and Release Constraints:

Conducting polymers and nanoparticles are examples of electric-stimulated systems that frequently have sluggish or irregular release kinetics and restricted drug-loading capabilities. High electroporation voltages have the potential to harm cells or break down delicate drugs¹².

· Cost and Regulatory Hurdles

Precision manufacturing and sophisticated materials are frequently needed for fabrication, which drives up production prices. The complicated regulatory approval processes for mixed electronic-drug devices might cause a delay in commercialization¹³.

· Limited Drug Types and Clinical Evidence

Many investigations are still being conducted on tiny animals or in vitro. Only a tiny number of drugs have been evaluated, primarily insulin or small compounds. For larger pharmacological classes, clinical validation is still in progress.

Electric tattoos have intriguing promise as intelligent, less invasive drug delivery systems, particularly when combined with feedback control and diagnostic sensors. However, they have significant obstacles to overcome, ranging from securing regulatory clearance and scaling up production to guaranteeing safe, long-term skin compatibility and strong performance under motion. These challenges could be overcome as research advances, opening the door for transdermal treatments of the future¹³.

3. Material Design and Skin Conformability:

· E‑tattoos are ultrathin, flexible patches (often <1 µm thick) composed of biomaterials like silk protein, cellulose nanofibers, graphene, carbon nanotubes (CNTs), or Pt‑based TMDs. These materials ensure breathability, biocompatibility, stretchability, and adhesion via van der Waals forces or bio‑adhesives without irritation¹⁴.

· Silk‑CNT networks, for instance, combine conductivity, flexibility, and porous architecture allowing stable integration with microheaters and sensors¹⁵.

4. Mechanisms of Electric Tattoo:

1. Thermal Activation (Thermally‑Enhanced Release /Thermoporation)

· Accelerated diffusion: Integrated micro‑heaters or optically‑driven layers raise skin temperature mildly (< 100°C for >1 s), increasing molecular kinetics and permeability of the stratum corneum, thereby enhancing passive diffusion of drug molecules^16,17.

· Thermoporation (thermal ablation): Short bursts (>100°C, <1 s) selectively disrupt the stratum corneum by loosening lipids or vaporizing keratin to create microchannels (~50–100µm) without damaging viable skin layers. This enables rapid delivery of both small and large biomolecules (peptides, nucleic acids)¹⁸.

Advantages: On‑demand control, compatibility with multiple drug types.

Limitations: Potential thermal damage if control fails, and higher power requirements.

2. Electrical Stimulation (Iontophoresis/ Electro‑Responsive Systems):

· Iontophoresis: Utilizes continuous low‑voltage current (typically 0.1–2 mA/cm² or ≤0.5 mA/cm² across 0.1–10 V) to transport charged drug molecules across skin via electro repulsion and electroosmotic flow. Skin permeability is also enhanced by the electric field itself ^19,20.

· Electro‑responsive polymer films: Electrically conductive polymers (e.g. polypyrrole) release drug cargo via redox-driven structural changes—oxidation triggers repulsion of positively charged molecules, while reduction causes contraction or stack disassembly in layer‑by‑layer (LbL) systems, enabling controlled release ²¹.

Advantages: Precise dose control, particularly effective for ionic drugs (e.g. insulin, peptides).

Limitations: Ineffective for neutral or large molecules without additional enhancement; skin irritation possible with prolonged exposure.

3. Microneedle‑Assisted Delivery:

· Types of microneedles (MNs): Solid, hollow, coated, dissolvable, or hydrogel‑forming arrays ranging from ~25 to 2000 µm in length that mechanically penetrate the stratum corneum to form microchannels²².

· Operation in e‑tattoos: MN arrays may be combined with heaters or electrodes:

Dissolving MNs embed drug in biodegradable polymers (e.g. silk fibroin, PVP), releasing it upon insertion Hydrogel‑forming MNs swell in situ, drawing interstitial fluid and enabling sustained release. Hollow MNs allow electrically assisted fluid injection through their bore ^23,24.

· Synergy with electrical methods: Iontophoresis or electroporation following MN puncture can significantly boost flux—especially for macromolecules—compared with either technique alone ²⁵.

Advantages: Minimally invasive, effective for large and hydrophilic drugs, rapid onset.

Limitations: Fabrication complexity, limited drug loading, potential for pore closure over time.

4. Electroporation:

· Mechanism: Short high‑voltage pulses (typically 50–500V; duration microseconds to milliseconds) induce transient nanopores in the stratum corneum and cell membranes, dramatically increasing permeability via electrophoresis and diffusion^25,41.

· Enhanced permeation: Studies show up to 4‑fold increases in macromolecule delivery (e.g. peptides, insulin, nucleic acids), and enable delivery of molecules >40 kDa that typically cannot cross intact skin^26,42.

· Parameter tuning: Pulse voltage, duration, and electrode design (e.g. serpentine vs planar) greatly affect efficiency and safety—longer pulses at moderate voltage (~100 ms, ~30–100 V) often yield better macromolecule transport while minimizing tissue damage ^27,43.

Advantages: Enables delivery of large biomolecules and drugs; pulsatile control.

Limitations: Requires precise electrical control; potential discomfort, erythema, and safety concerns with improper parameters.

5. Integration and Functional Workflow:

Table 2: Functional workflow of e-tattoo

Step	Function
Skin application	Ultra-thin e‑tattoo laminated onto skin; high conformity without discomfort
Sensing	Continuous detection of physiological markers via integrated sensors
Triggering	Based on stimuli (heat, current, mechanical tension) or sensor feedback
Drug release	Delivered via iontophoresis, polymer actuation, thermal diffusion, or microneedles
Control	Closed-loop system enhances precision, dosage, and timing
Removal	The tattoo naturally peels off after wear time or by intentional removal

6. Application of Electronic Tattoos as Drug Delivery Systems:

Theranostic Integration: Sensing+Therapeutic Actuation:

Multifunctional e-tattoos that integrate on-demand administration of drugs and real-time physiological monitoring have been made possible by recent breakthroughs. For example, temperature sensors, micro-heaters, and drug reservoirs are used in ultrathin silk nanofiber/CNT e-tattoos to administer molecules like insulin in response to local thermal or electrophysiological stimuli^28,29,33.

Iontophoretic Transdermal Delivery:

Silk-protein e-tattoos were specially designed for iontophoretic drug delivery in a noteworthy 2025 study. These ultra conformal, breathable patches use low-level currents to transfer ionic medicines over the skin, providing precise timing and dose control in a less intrusive manner^30,34,35.

Potential for Chemotherapeutic and Biologic Applications:

Under applied voltages, electro-responsive materials (conductive polymer films, nanoparticles, etc.) implanted in e-tattoos have shown regulated release of a variety of treatments, such as insulin-loaded hydrogels or anticancer drugs. This reduces off-target effects and allows for localized, focused therapy^36,37,38.

Future Innovations:

Electroporation and Hybrid Modalities:

Similar tissue nano transfection techniques demonstrate that electric pulses delivered via nanochannel arrays may deliver gene constructs and drugs transdermally with accurate dosage, even if direct electroporation-enabled e-tattoos are still in their infancy. This encourages the creation of e-tattoos that can be delivered by electroporation, particularly when paired with ultrasonic or microneedle methods^31,32,39,40.

ABBREVIATION:

E-tattoo: Electric tattoo.

CNTs: Carbon nanotubes

LbL: layer- by- layer

MNs: Microneedles

ACKNOWLEDGEMENT:

Authors are thankful to our respected Principal sir, Prof. (Dr.) V. P. Ramachandran, Vice- Principal sir Prof. (Dr.) Subhabrota Majumdar of Calcutta Institute of Pharmaceutical Technology and Allied Health Science, Howrah, India.

AUTHORS’ CONTRIBUTIONS:

We affirm that the writers listed in this article completed this research work. Dr. Subhabrota Majumdar contributed to conceptualization, methodology, formal analysis and Banhishikha Kar contributed to the supervision, writing review, and editing the project. Dipannita Naskar has contributed to writing of original draft preparation also formatted and removed typological errors from the manuscript.

CONFLICTS OF INTEREST:

The authors declare that there are no conflicts of interest. The authors alone are responsible for the content and writing of this article.

REFERENCES:

1. Sharova AS, Melloni F, Lanzani G, Bettinger CJ, Caironi M. Edible electronics: The vision and the challenge. Advanced Materials Technologies. 2021 Feb; 6(2): 2000757.

2. Hoang MC, Park JO, Kim J. Battery-free tattooing mechanism-based functional active capsule endoscopy. Micromachines. 2022 Nov 29; 13(12): 2111.

3. de Vasconcelos LS, Yan Y, Maharjan P, Kumar S, Zhang M, Yao B, Li H, Duan S, Li E, Williams E, Tiku S. On-scalp printing of personalized electroencephalography e-tattoos. Cell Biomaterials. 2025 Feb 25;1(1).

4. Cao Y, Kakar P, Hossen MN, Wu MX, Chen X. Sustained epidermal powder drug delivery via skin microchannels. Journal of Controlled Release. 2017 Mar 10; 249:94-102.

5. Alkilani AZ, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H, Donnelly RF. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics. 2022 May 28; 14(6): 1152.

6. Gao Y, Zhang H, Song B, Zhao C, Lu Q. Electric double layer based epidermal electronics for healthcare and human-machine interface. Biosensors. 2023 Aug 3; 13(8): 787.

7. Liu S, Deng T, Cheng H, Lu J, Wu J. Advances in Transdermal Drug Delivery Systems and Clinical Applications in Inflammatory Skin Diseases. Pharmaceutics. 2025 Jun 6; 17(6): 746

8. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Therapeutic Delivery. 2010 Jul 1;1(1):109-31.

9. Dong J, Hou J, Peng Y, Zhang Y, Liu H, Long J, Park S, Liu T, Huang Y. Breathable and stretchable epidermal electronics for health management: recent advances and challenges. Advanced Materials. 2024 Dec; 36(49): 2409071.

10. Lee CH, Kim H, Harburg DV, Park G, Ma Y, Pan T, Kim JS, Lee NY, Kim BH, Jang KI, Kang SK. Biological lipid membranes for on-demand, wireless drug delivery from thin, bioresorbable electronic implants. NPG Asia Materials. 2015 Nov;7(11):e227-.

11. Gogurla N, Kim Y, Cho S, Kim J, Kim S. Multifunctional and ultrathin electronic tattoo for on‐skin diagnostic and therapeutic applications. Advanced Materials. 2021 Jun;33(24):2008308

12. Zaid Alkilani A, McCrudden MT, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015 Oct 22;7(4):438-70.

13. Liu G, Lu Y, Zhang F, Liu Q. Electronically powered drug delivery devices: Considerations and challenges. Expert Opinion on Drug Delivery. 2022 Dec 2;19(12):1636-49.

14. Kireev D, Okogbue E, Jayanth RT, Ko TJ, Jung Y, Akinwande D. Multipurpose and reusable ultrathin electronic tattoos based on PtSe2 and PtTe2. ACS nano. 2021 Jan 20; 15(2):2800-11.

15. Joshi SR, Lee S, Kim S. Semiconducting and environmentally responsive melanin-doped silk nanofibers for multifunctional electronic tattoos. Materials Horizons. 2025; 12(12): 4444-56.

16. Alex M, Alsawaftah NM, Husseini GA. State-of-all-the-art and prospective hydrogel-based transdermal drug delivery systems. Applied Sciences. 2024 Mar 30; 14(7): 2926.

17. Machado N, Callegaro C, Christoffolete MA, Martinho H. Tuning the Transdermal Transport by Application of External Continuous Electric Field: A Molecular Dynamics Coarse-Grained Study. arXiv preprint arXiv:1905.02183. 2019 May 6.

18. Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: A review. Biomaterials research. 2021 Jul 28; 25(1): 24.

19. Han J, Choi YJ, Kang SK. Synergistic strategies of biomolecular transport technologies in transdermal healthcare systems. Advanced Healthcare Materials. 2024 Dec; 13(30): 2401753

20. Lee DH, Lim S, Kwak SS, Kim J. Advancements in skin‐mediated drug delivery: Mechanisms, techniques, and applications. Advanced Healthcare Materials. 2024 Mar; 13(7): 2302375.

21. Ramadon D, McCrudden MT, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug delivery and translational research. 2022 Apr;12(4): 758-91.

22. Bakhrushina EO, Shumkova MM, Avdonina YV, Ananian AA, Babazadeh M, Pouya G, Grikh VV, Zubareva IM, Kosenkova SI, Krasnyuk Jr II, Krasnyuk II. Transdermal Drug Delivery Systems: Methods for Enhancing Skin Permeability and Their Evaluation. Pharmaceutics. 2025 Jul 20;17(7):936.

23. Donnelly RF, Garland MJ, Alkilani AZ. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery. InDrug delivery system 2014 Feb 3 (pp. 121-132). New York, NY: Springer New York.

24. Abbasi M, Heath B. Iontophoresis and electroporation-assisted microneedles: Advancements and therapeutic potentials in transdermal drug delivery. Drug delivery and translational research. 2025 Jun; 15(6):1962-84.

25. Bhat M, Tharmatt A, Bhargava S, Kumeria T, Mishra A, Mittal A, Chitkara D. Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics. Journal of Translational Medicine. 2025 May 7; 23(1): 513.

26. Li X, Qin G, Yang Q, Chen L, Xie L. Biomolecular network‐based synergistic drug combination discovery. BioMed research international. 2016; 2016(1): 8518945.

27. Lee DH, Lim S, Kwak SS, Kim J. Advancements in skin‐mediated drug delivery: Mechanisms, techniques, and applications. Advanced Healthcare Materials. 2024 Mar; 13(7): 2302375.

28. Williams NX, Franklin AD. Electronic tattoos: A promising approach to real-time theragnostics. Journal of Dermatology and Skin Science. 2020 Mar 2; 2(1).

29. Li H, Tan P, Rao Y, Bhattacharya S, Wang Z, Kim S, Gangopadhyay S, Shi H, Jankovic M, Huh H, Li Z. E-Tattoos: Toward functional but imperceptible interfacing with human skin. Chemical reviews. 2024 Mar 11; 124(6): 3220-83..

30. Joshi SR, Lee H, Lee S, Choi J, Kim S. Ultrathin and Breathable Silk-Protein Electronic Tattoos for Iontophoretic Transdermal Drug Delivery. ACS Applied Polymer Materials. 2025 Mar 24; 7(7): 4457-67.

31. Jang H, Sel K, Kim E, Kim S, Yang X, Kang S, Ha KH, Wang R, Rao Y, Jafari R, Lu N. Graphene e-tattoos for unobstructive ambulatory electrodermal activity sensing on the palm enabled by heterogeneous serpentine ribbons. Nature Communications. 2022 Nov 3; 13(1): 6604.

32. Pirrera A, Giansanti D. Smart Tattoo Sensors 2.0: A Ten-Year Progress Report through a Narrative Review. Bioengineering. 2024 Apr 13; 11(4): 376.

33. Rupali M. Ghule, Nikita S. Andhale. A Review on Oral Controlled Release Drug Delivery System. Asian Journal of Pharmacy and Technology. 2025; 15(3): 271-6.

34. Umang Budhraja, Prasad Angane, Mohd Fareed Shaikh, Anamika Mishra. Microencapsulation Technology in Food, Pharma and Cosmetics. Asian Journal of Pharmacy and Technology. 2025; 15(2): 166-2.

35. Prakash Nathaniel Kumar Sarella, Surekha Valluri, Srujala Vegi, Veera Kumari Vendi, Anil Kumar Vipparthi. Microneedle Arrays: Advancements, Applications and Future Prospects in Pharmaceutical Delivery. Asian Journal of Pharmacy and Technology. 2024; 14(3): 229-6.

36. Arindam Chatterjee, Amrita Pandey, Mayank Bansal, Sunil Sain, Ashutosh Sharma. A Panoramic Review on Microparticles. Asian Journal of Pharmaceutical Research. 2024; 14(3): 285-8.

37. Shailesh S. Chalikwar, Kailas K. Moravakar, Bhushan A. Bhairav. Stability Indicating Method Development and Validation for Estimation of Valacyclovir in Pharmaceutical Preparation. Asian Journal of Pharmaceutical Analysis. 2024; 14(2): 53-9.

38. Kashish R. Mulani, B. P. Chaudhari, V. K. Redasani, Kalyani Gardi. Drug Discovery and Development. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(3): 293-8.

39. Bhavika C. Patle. Introduction to Nanoparticles in Pharmacy: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(4): 367-2.

40. Priyanka A. Mandal, Nilakshi N. Dhoble, Nitin Padole, Pankaj Dhapke, Jagdish R. Baheti. Niosomal-based Drug Delivery System: A Novel Target Strategy for the Treatment of Arthritis. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(2): 139-5.

41. Petukhov, AN, Atlaskin, AA, Smorodin, KA, Atlaskina, ME, Zarubin, DM, Kryuchkov, SS, Stepakova, AN, Vorotyntsev, AV, Kazarina, OV, Suvorov, SS, Stepanova, EA and Vorotyntsev. An efficient technique to remove acid gases from natural gas with a hollow fiber-based membrane-assisted gas absorption unit. International Journal of Technology. 2025; 16(5): 1630-50

42. Sachin Panchal, Hindustan Abdul Ahad, Hashitha Srinivas, Gaanavi B. Ramachandra, Monish Gangadharaiah, Sunidhi Srinivas. Breaking Barriers in Ocular Drug Delivery: Unveiling the Role of Ocular Inserts as Controlled Release Systems. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(3): 245-50

Received on 02.09.2025 Revised on 18.12.2025

Accepted on 20.02.2026 Published on 04.07.2026

Available online from July 18, 2026

Asian J. Pharm. Tech. 2026; 16(3):317-321.

DOI: 10.52711/2231-5713.2026.00044

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

Mechanism	Stimulus Type	Drug Types	Key Advantages	Limitations
Thermal Activation	Heat (microheater/laser)	Hydrophilic and hydrophobic	On‑demand, simple actuation	Risk of overheating, power needed
Iontophoresis / Electro‑responsive	DC current, redox voltage	Charged molecules (peptides, ions)	Precise dose control, non-invasive	Limited for neutral drugs; skin irritation possible
Microneedles	Mechanical puncture ± electrical	Macromolecules, vaccines, peptides	Direct delivery to epidermis, minimal pain	Fabrication complexity, limited capacity
Electroporation	High‑voltage pulses	Large biomolecules (≥40 kDa), peptides, genes	High permeability, pulsatile control	Safety/tolerability, pulse optimization needed